Ujin Pharma Limited gets SEBI nod for its IPO
Mumbai, October 01, 2026: Mumbai – based Ujin Pharma Limited receives final SEBI approval for IPO The Company had filed its IPO papers with SEBI on 22 June, 2026. The IPO consists of a fresh issue of up to 11,869,100 equity shares and an offer-for-sale for up to 7,282,300 equity shares by promoters - Jinesh Rasiklal Sheth and Umang Ketan Mehta. The proceeds from its fresh issuance worth Rs 61.7 crore will be utilised for investment in Altra Agro-Chem Private Limited - the company’s associate company, by way of subscription to equity shares for making it their subsidiary, Rs 21.6 crore in investment in Altra Pharma-Chem Private Limited, its associate company, by way of subscription to equity shares for making it their subsidiary, Rs 25 crore for repayment or pre-payment, in part or full, of certain borrowings availed by the company from financial institutions, and general corporate purposes. Incorporated in 2005, the company is engaged in the distribution and supply of a di...